Results 301 to 310 of about 11,679,175 (389)

Light‐Harvesting Nanomaterials Based on Dyes for Energy Transfer and Amplified Biosensing

open access: yesAdvanced Materials, EarlyView.
Light harvesting (LH) in plants inspires researchers to develop artificial LH nanomaterials. Here, LH nanomaterials based on organic dyes are reviewed, considering fundamental challenges on aggregation‐caused quenching, excitation energy transfer, and exciton migration length.
Andrey S. Klymchenko   +2 more
wiley   +1 more source

Gene- and cell-based therapy in cardiovascular diseases. [PDF]

open access: yesJ Cardiovasc Pharmacol
Zhang C, Du Z, Chen R, Liu X, Li D.
europepmc   +1 more source

Unperceivable Designs of Wearable Electronics

open access: yesAdvanced Materials, EarlyView.
Unperceivable wearable technologies seamlessly integrate into everyone's daily life, for healthcare and Internet‐of‐Things applications. By remaining completely unnoticed both visually and tactilely, by the user and others, they ensure medical privacy and allow natural social interactions.
Yijun Liu   +2 more
wiley   +1 more source

Anomalous Origin of the Right Coronary Artery/circumflex from the Pulmonary Artery (ARPACA) - Exercise Induced VT

open access: yesJournal of Cardiovascular Magnetic Resonance
Vladimir Mihajlovic, MD   +7 more
doaj   +1 more source

Wireless Acousto‐Piezoelectric Conduit with Aligned Nanofibers for Neural Regeneration

open access: yesAdvanced Materials, EarlyView.
An ultrasound‐driven, highly aligned piezoelectric nanofiber‐based nerve guidance conduit (APNF‐NGC) designed for effective peripheral nerve repair has been demonstrated in this study. Featuring aligned topology, cell‐adhesive surfaces, and an axial electric field, the APNF‐NGC collectively promotes significant nerve regeneration.
Sera Jeon   +8 more
wiley   +1 more source

MUTE‐Seq: An Ultrasensitive Method for Detecting Low‐Frequency Mutations in cfDNA With Engineered Advanced‐Fidelity FnCas9

open access: yesAdvanced Materials, EarlyView.
An advanced‐fidelity CRISPR nuclease, FnCas9‐AF2, is rationally engineered to discriminate single‐base mismatches with unprecedented level precision. Integrated into the MUTE‐Seq workflow, FnCas9‐AF2 depletes wild‐type cell‐free DNA, thereby exposing rare tumor‐derived mutant DNA (a molecular “needle in a haystack”).
Sunghyeok Ye   +20 more
wiley   +1 more source

Home - About - Disclaimer - Privacy